(주) 뷰노

Press Releases

VUNO Signs License Agreement with M3 … a Giant Step Towards the Japanese Market

  • 06. 18. 2020

VUNO Signs License Agreement with M3 … a Giant Step Towards the Japanese Market

VUNO Inc., South Korean artificial intelligence (AI) developer announced on June 18 that it signed a license agreement with M3, one of Sony's subsidiaries, to distribute its AI solutions in the Japanese market. This agreement allows VUNO to strategically approach and make inroads into the conservative Japanese medical market, harnessing M3’s sizable body of data.

M3 is Japan’s largest medical informational platform company of which Sony owns 33.9% of the shares. It has 280 thousand members who are part of the medical community and have a diverse business portfolio in the medical field including clinical research planning, pharmaceutical company marketing consultation, and telemedicine.

M3 embraced the medical AI industry as its new growth engine a few years ago and has since fostered its capabilities in the related fields in collaboration with world leading AI firms. Among many prominent companies, VUNO is the first overseas company to sign a sales contract with M3. Recently, M3 established a joint venture with Line, a Naver’s affiliate, to spur forth its telemedicine project. 

VUNO now plans to safely deploy its VUNO Med series in the Japanese market which has higher entry barriers, galvanizing M3’s extensive distribution and hospital networks within Japan. VUNO also seeks to sell its lung CT diagnostic supporting tool which already received regulatory approval in Japan, on M3’s AI medical device sales platform, and is also actively collaborating with M3 to launch other AI-powered medical devices that are to gain approval in the near future.

Hyun-Jun Kim, CEO of VUNO said “signing a license agreement with M3, a medical data company that has an extensive online distribution network in Japan is a remarkable business achievement,” and further added that “this will contribute to an increase in VUNO’s sales by targeting the Japanese medical device market, one of the largest in the world, and we will continue to push forth with tackling the world medical market in collaboration with global companies and institutions that are currently partnered with VUNO, going forward.”

For more detailed information on VUNO, visit https://www.vuno.co/.

 

Article URL (Kor.): https://www.etnews.com/20200618000156?fbclid=IwAR1NfQ_XYEIij490Xx_akN8w0lqYrT4CPCanYFzWUgLYdmMse41NW2UF42s

Article URL (Eng.): http://www.koreaherald.com/view.php?ud=20200619000660&fbclid=IwAR2mJwBZ3ieeWm9Nw4hx8chEJSPCpHe2wtPgd2fSoNRi-h-rgyyCjLdsE-A

 

Contact Information

Yerim Kim / PR Manager, VUNO lnc.   

Email: rim@vuno.co

Tag in

#Press_Releases

#VUNO Med® Solution